Nitrous oxide activates layer 5 prefrontal neurons via SK2 channel inhibition for antidepressant effect.
Joseph Cichon, Thomas Joseph, Xinguo Lu, Andrzej Z Wasilczuk, Max B Kelz, Steven Mennerick, Charles F Zorumski, Peter Nagele
Nature Communications April 3, 2025 DOI: 10.1038/s41467-025-57951-y (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical study Peer reviewed |
|---|---|
| Population | Rodents exposed to chronic stress conditions |
| Intervention | Nitrous oxide |
| Dose | single dose |
| Key points | Nitrous oxide induces rapid and specific activation of layer V pyramidal neurons in the cingulate cortex via inhibition of SK2 channels, which is necessary for its antidepressant-like effects. |
Abstract
Nitrous oxide (N2O) induces rapid and durable antidepressant effects. The cellular and circuit mechanisms mediating this process are not known. Here we find that a single dose of inhaled N2O induces rapid and specific activation of layer V (L5) pyramidal neurons in the cingulate cortex of rodents exposed to chronic stress conditions. N2O-induced L5 activation rescues a stress-associated hypoactivity state, persists following exposure, and is necessary for its antidepressant-like activity. Although NMDA-receptor antagonism is believed to be a primary mechanism of action for N2O, L5 neurons activate even when NMDA-receptor function is attenuated through both pharmacological and genetic approaches. By examining different molecular and circuit targets, we identify N2O-induced inhibition of calcium-sensitive potassium (SK2) channels as a key molecular interaction responsible for driving specific L5 activity along with ensuing antidepressant-like effects. These results suggest that N2O-induced L5 activation is crucial for its fast antidepressant action and this effect involves novel and specific molecular actions in distinct cortical cell types.
Citations in the library
Cited by 7
- Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain Nature Neuroscience October 2, 2025
- Rapid antidepressant potential of nitrous oxide: current state and major questions. Molecular Psychiatry June 1, 2026
- Nitrous oxide for late-life depression with inadequate antidepressant response: a randomised controlled trial. EClinicalMedicine April 2, 2026
- Nitrous oxide promotes exploratory activity and stimulates neurogenesis in a male rat model of post-traumatic stress disorder. Neuroscience January 26, 2026
- Nitrous oxide for the treatment of depression: a systematic review and meta-analysis. EBioMedicine December 1, 2025
and 2 more in the library
Cites 10
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry August 1, 2006
- Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines Nature Communications June 3, 2019
- NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine Journal of Neuroscience January 3, 2023
- Nitrous Oxide, a Rapid Antidepressant, Has Ketamine-like Effects on Excitatory Transmission in Adult Hippocampus Biological Psychiatry June 1, 2022
- A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression. Science Translational Medicine June 9, 2021
and 5 more in the library